Feni Fitriani Taufik

Feni Fitriani Taufik

Auto-generated profile, based on publicly available information

Feni Fitriani Taufik

Persahabatan Central General Hospital

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2023 in Jurnal Respirasi
Verified
Journal Article
Open access
PDF file
YPYolanda Edith Pratiwi
Yolanda Edith Pratiwi
FTFeni Fitriani Taufik
Feni Fitriani Taufik
JHJanuar Habibi
Januar Habibi
AWAdityo Wibowo
Adityo Wibowo
Nowadays, around 50% of the world's population lives in cities and urban areas and is exposed to increasingly higher levels of air pollutants including gaseous pollutants and particulate matter (PM). The latter is a key indicator of air pollution transported into the air by a variety of natural processes and human activities. The particles’ size has been directly related to their potential impact on health problems. Particles of concern include small particles with diameters of 2.5 to 10 μm (coarse particles) and smaller than 2.5 μm (fine particles). Exposure to air pollutants over a long period of time not only decompensates pre-existing diseases but also leads to pulmonary and respiratory health problems such as asthma, chronic obstructive pulmonary disease (COPD), and lung cancer even in rural areas. A thorough analysis has to be provided to address the implications for policymakers. Hence, more stringent strategies can be implemented to control air pollution and prevent its health effects.

1 January 2021 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
SPSri Wening Pamungkasningsih
Sri Wening Pamungkasningsih
FTFeni Fitriani Taufik
Feni Fitriani Taufik
ESErlang Samoedro
Erlang Samoedro
SASita Andarini
Sita Andarini
ASAgus Dwi Susanto
Agus Dwi Susanto
Objective: Found in plasma, urine, and saliva, cotinine can be used as a biomarker for nicotine in electronic cigarette (e-cig) users. Nicotine is addictive and causes dependence. Thus, it becomes a problem in smoking cessation programs. This study aimed to determine the relationship between urinary cotinine (UCot) and nicotine dependence levels in regular male e-cig users. Materials and Methods: This cross-sectional study consecutively included regular male e-cig users and nonsmokers. All subjects were interviewed and had their UCot levels measured using an enzyme-linked immunosorbent assay method. The regular e-cig users completed the Penn State Nicotine Dependence Index questionnaire. Results: This study recruited 71 males aged 18-45 years divided into e-cig users and non-smokers group. The predominating characteristics in e-cig users are as follows: 23 males (67.6%) aged <30 years, the highest education of senior high school 25 (73.5%) and 25 (73.5%) subjects had occupation. The UCot levels among the e-cig users in the non-dependency group were lower than that of the medium-high dependency group (P = .008). The median value for UCot level in the regular e-cig users was higher than that of the non-smoker group (276.11 [58.01-284.15] ng/mL vs 5.21 [4.65-23.72] ng/mL, P < .001). Factors influencing the UCot levels of the e-cig users were age (P = .041), nicotine level of the e-cig liquid (P = .013), and the flavor of the e-cig liquid (eg, menthol or non-menthol; P = .040). Conclusion: UCot and nicotine dependence levels in the regular male e-cig users were significantly related. Nicotine dependence was found in 76.5% of the regular male e-cig users. The UCot levels in the e-cig users were significantly higher than in the non-smokers. Cite this article as: Pamungkasningsih SW, Taufik FF, Samoedro E, Andarini S, Susanto AD. Urinary cotinine and nicotine dependence levels in regular male electronic cigarette users. Eurasian J Med. 2021; 53 (03):168–173

19 November 2021 in Respirology
Verified
Journal Article
Open access
PDF file
NPNesia Priandari
Nesia Priandari
WWWiwien Heru Wiyono
Wiwien Heru Wiyono
FYFaisal Yunus
Faisal Yunus
BABudhi Antariksa
Budhi Antariksa
FIFathiyah Isbaniah
Fathiyah Isbaniah
HLHui Fang Lim
Hui Fang Lim
Click on the article title to read more.

30 April 2024 in Düzce Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
PDF file
FFFanny Fachrucha
Fanny Fachrucha
RPRossy Ardhia Pramesti
Rossy Ardhia Pramesti
MEMia Elhidsi
Mia Elhidsi
SASita Andarini
Sita Andarini
PPPrasenohadi Prasenohadi
Prasenohadi Prasenohadi
MSMeilania Saraswati
Meilania Saraswati
In this case report, a 40-year-old male patient with a persistent and productive cough lasting over 2 weeks, accompanied by dyspnea, who received an anti-tuberculosis drug regimen for 12 months without any clinical improvement at a different hospital before being referred to Persahabatan Central General Hospital was presented. In-depth clinical, and radiological investigations, the periodic acid-Schiff (PAS)-positive related to pulmonary alveolar proteinosis (PAP) confirmed through transbronchial biopsy (TBB). PAP is a rare lung disease with exceptionally low prevalence and incidence, Notably, the patient’s occupational environment played a crucial role in the diagnosis, as we identified occupational PAP secondary to chronic inhalation of ethylene oxide in a poorly ventilated work setting and inadequate respiratory protection. The patient was administered inhaled filgrastim (1 vial) at four intervals over 30 days, yielding favorable and satisfactory clinical as well as radiological outcomes.

26 October 2026 in Asia Pacific Journal of Public Health
Verified
Journal Article
Open access
CBChristopher Bullen
Christopher Bullen
FTFeni Fitriani Taufik
Feni Fitriani Taufik
IMImelda Mateo
Imelda Mateo
MMMohamad Haniki Bin Nik Mohamed
Mohamad Haniki Bin Nik Mohamed
VNViet Nhung Nguyen
Viet Nhung Nguyen
ANAmer Siddiq Bin Amer Nordin
Amer Siddiq Bin Amer Nordin
Most Association of Southeast Asian Nations (ASEAN) countries have ratified the World Health Organization Framework Convention on Tobacco Control and adopted MPOWER measures, but disparities persist regarding the help available to quit tobacco use, encompassing smoking cessation treatments, clinical practice guidelines, health care professional (HCP) training and policy implementation. This expert review evaluates the smoking cessation landscape across ASEAN, identifies barriers and proposes strategies to enhance cessation efforts. The ASEAN Advisory Board on Smoking Cessation, formed in 2023 with 9 experts from 7 countries, aimed to establish best practices and optimize pharmacological and behavioural interventions through a structured advisory board discussion. Two advisory board meetings in 2023 and 2024, supported by a targeted PubMed literature review, informed 12 recommendations to address gaps in pharmacotherapy access, behavioural support, HCP training and policy implementation. Key opportunities include standardized policies, advocating improved pharmacotherapy access, regulatory frameworks for each country and sharing HCP training resources and expertise. Areas of improvement for each country include integrating cessation services into primary care, expanding digital interventions and developing targeted strategies for high-risk populations, including pregnant women, adolescents and individuals with mental illnesses. Increased regional collaboration is vital for harmonizing policies, practices and HCP training, thus ensuring greater, more equitable access to evidence-based cessation support.